The contract provides coverage of ConfirmMDx testing at the Medicare rate for veterans within the VA health system.
The company will apply artificial intelligence to a large clinical and genomic dataset from VA records in order to support personalized clinical decision making.
The new partnership will make data from more than 9 million anonymized veterans' medical records available for research.
The company has been working with the VA since 2013, when it it received a contract to provide sequencing and data analysis for enrollees in the Million Veteran Program.
Announced this month, the project brings together CPTAC, the VA, and DoD, and has as its initial goal the proteogenomic analysis of 8,000 lung cancer patients.
With NIH funds, organizations will build the 1 million volunteer cohort, while FDA's draft guidances will inform regulation of genetic tests critical for precision medicine.
The deal, which will help develop personalized cancer treatments for veterans, marks the latest in a series of personalized medicine alliances for IBM.
The work will support the Million Veteran Program, which aims to study the link between genes and disease using a research cohort veterans and active military.
Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.
If the regional precision medicine program is successful, the VA might expand it for veterans around the country.
In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.
An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.
The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.
For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.